Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-033189

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Mitchall G. Clark
Officer — EVP & Chief R & QA Officer
Period of report
May 15, 2017
Accepted (ET)
May 17, 2017 · 4:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 15, 2017M7,212$0.00A156,873D
Common StockMay 16, 2017S3,873$15.25D153,000D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitesF4,F5,F6—May 15, 2017M7,212D——Common Stock7,21226,442D

Explanation of responses